Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate

There is currently no therapeutic drug treatment for traumatic brain injury (TBI) despite decades of experimental clinical trials. This may be because the mechanistic pathways for improving TBI outcomes have yet to be identified and exploited. As such, there remains a need to seek out new molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Hook, Gregory, Jacobsen, J. Steven, Grabstein, Kenneth, Kindy, Mark, Hook, Vivian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557097/
https://www.ncbi.nlm.nih.gov/pubmed/26388830
http://dx.doi.org/10.3389/fneur.2015.00178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557097/
https://www.ncbi.nlm.nih.gov/pubmed/26388830
http://dx.doi.org/10.3389/fneur.2015.00178

Ejemplares similares